跳至主要内容
临床试验/JPRN-UMIN000018914
JPRN-UMIN000018914已完成未知

Clinical trial of colon cancer diagnostic reagent by blood mRNA examination for practical use - Clinical trial of colon cancer diagnostic pharmaceutical by blood mRNA examination

Kanazawa University0 个研究点目标入组 200 人开始时间: 2015年9月4日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • The patients who meet any of the criteria below will be excluded. 1) Patients who have been diagnosed with malignancy within 5 year of the date of the informed consent. 2) Patients who have been treated with interferon treatment within one year of the date of the informed consent, or is currently undergoing interferon treatment. 3) Patients who have been treated with adrenal hormone (except for local treatment) or biological drug (etc. infliximab) within 6 months. 4) Patients who have been treated with anti-cancer drug within 6 months of the informred consent. 5) Patients who are infected with hepatitis B, hepatitis C or other infectious diseases. 6) Patients who have been diagnosed with irritable bowel syndrome, ulcerative colitis, and Crohn disease. 7)Patients, who are judged to be not appropriate for entry by the trial responsible (collaborative) doctor

研究者

相似试验